Immunometabolism in cancer: basic mechanisms and new targeting strategy

Ranran Su,Yingying Shao,Manru Huang,Donghui Liu,Haiyang Yu,Yuling Qiu

DOI: https://doi.org/10.1038/s41420-024-02006-2

2024-05-17

Cell Death Discovery

Abstract:Maturing immunometabolic research empowers immune regulation novel approaches. Progressive metabolic adaptation of tumor cells permits a thriving tumor microenvironment (TME) in which immune cells always lose the initial killing capacity, which remains an unsolved dilemma even with the development of immune checkpoint therapies. In recent years, many studies on tumor immunometabolism have been reported. The development of immunometabolism may facilitate anti-tumor immunotherapy from the recurrent crosstalk between metabolism and immunity. Here, we discuss clinical studies of the core signaling pathways of immunometabolism and their inhibitors or agonists, as well as the specific functions of these pathways in regulating immunity and metabolism, and discuss some of the identified immunometabolic checkpoints. Understanding the comprehensive advances in immunometabolism helps to revise the status quo of cancer treatment.

cell biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is how immune cells enhance the effect of anti - tumor immunotherapy through metabolic reprogramming in the tumor microenvironment. Specifically, the paper explores the following aspects:

1. **Metabolic vulnerability of immune cells in the tumor microenvironment**: The paper points out that immune cells may lose their initial killing ability due to insufficient metabolic flexibility in the tumor microenvironment, which leads to an immunosuppressive state in the tumor microenvironment.

2. **Metabolic pathways as an effective means of regulating immune responses**: The paper discusses the possibility of regulating immune responses by targeting the metabolic pathways of immune cells, especially enhancing the effect of anti - tumor immunotherapy through the interaction between metabolism and immunity.

3. **Core signaling pathways and their regulatory mechanisms**: The paper focuses on the roles of two core signaling pathways, PI3K/AKT/mTOR and LKB1 - AMPK, in immunometabolism, and how these pathways regulate immune and metabolic functions.

4. **Potential applications of immunometabolic checkpoints**: The paper also introduces some discovered immunometabolic checkpoints and explores their potential application values in cancer treatment.

In summary, this paper aims to provide new strategies and methods for cancer treatment, especially in immunometabolic regulation, through a comprehensive analysis of the latest progress in the field of immunometabolism.